Advertisement
UK markets closed
  • NIKKEI 225

    38,073.98
    -128.39 (-0.34%)
     
  • HANG SENG

    18,537.81
    +223.95 (+1.22%)
     
  • CRUDE OIL

    79.15
    +0.16 (+0.20%)
     
  • GOLD FUTURES

    2,341.40
    +19.10 (+0.82%)
     
  • DOW

    39,322.05
    +265.66 (+0.68%)
     
  • Bitcoin GBP

    49,653.00
    -438.79 (-0.88%)
     
  • CMC Crypto 200

    1,333.89
    +33.79 (+2.60%)
     
  • NASDAQ Composite

    16,336.80
    +34.05 (+0.21%)
     
  • UK FTSE All Share

    4,558.37
    +14.13 (+0.31%)
     

Shire launches US$12.1bn four-part deal: Lead

(Adds launch levels)

By Mike Gambale and Hillary Flynn

NEW YORK, Sept 19 (IFR) - Here is the pricing progression on

the new bond offering from drugmaker Shire (Hamburg: 3979575.HM - news) (Baa3/BBB-) to help

finance its acquisition of Baxalta (Berlin: 9BX.BE - news) , one of the banks leading the

deal told IFR.

The deal is expected to price later on Monday.

SIZE MATURITY IPTs (T+) Guidance Launch (T+)

(T+)

US$3.3bn 3yr FXD 120-125bp 105bp 100bp

area*

US$3.3bn 5yr FXD 140-145bp 125bp 120bp

area

US$2.5bn 7yr FXD 160-165bp 140bp 135bp

area

US$3bn 10yr FXD 175-180bp 155bp 150bp

area

Active bookrunners: Bank of America Merrill Lynch, Barclays (LSE: BARC.L - news) ,

Morgan Stanley (Xetra: 885836 - news)

* Area is +/- 5bp area

(Reporting by Mike Gambale; Editing by Natalie Harrison, Marc

Carnegie and Paul Kilby)